Director, Magnetic Resonance Science Center; Professor in Residence, Radiology, UCSF
| CONTACT | |
|
Nola.Hylton@radiology.ucsf.edu Box 1290, UCSF; San Francisco, CA 94143-1290 |
| EDUCATION | |
|
Massachusetts Institute of Technology (M.I.T.), B.S., 1979, Chemical Engineering
|
|
| PROFESSIONAL EXPERIENCE | |
|
6/76-8/76 |
Technical Associate, Bell Telephone Laboratories, Murray Hill, N.J. |
|
6/77-8/77 |
Research Assistant, Bell Telephone Laboratories, Murray Hill, N.J. |
|
6/78-8/78 |
Research Assistant, Bell Telephone Laboratories, Murray Hill, N.J. |
|
9/79-12/82 |
Research Assistant, E. L. Ginzton Laboratory, Stanford University, Stanford,California |
|
1/83-12/84 |
Research Assistant, Radiologic Imaging Laboratory, Department of Radiology, University of California, San Francisco |
|
1/85-7/92 |
Assistant Professor, Radiologic Imaging Laboratory, Department of Radiology, University of California, San Francisco |
|
7/90-9/97 |
Faculty Member, Graduate Group in Biophysics, University of California, San Francisco |
|
7/92-6/95 |
Assistant Professor, Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco |
|
7/95-6/02 |
Associate Adjunct Professor, Magnetic Resonance Science Center Department of Radiology, University of California, San Francisco |
|
9/97-present |
Faculty Member, Bioengineering Graduate Group, University of California, San Francisco and University of California, Berkeley |
|
1/98-present |
Faculty Member, Breast Oncology Program, UCSF Cancer Center |
|
7/02-present |
Professor in Residence, Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco |
|
2/04-present |
Director, Magnetic Resonance Science Center, Dept. of Radiology, UCSF |
| SELECTED PUBLICATIONS | |
|
Ortendahl DA, Hylton NM, Kaufman L, Crooks LE. Signal-to-noise in derived NMR images. Magn Reson Med. 1984 Sep;1(3):316-38. | |
|
Ortendahl DA, Hylton NM, Kaufman L, Watts J, Crooks LE, Mills CM and Stark D: Analytical tools for magnetic resonance imaging. Radiology 1984 Nov;153(2):479-88. | |
|
Crooks LE, Hylton NM, Ortendahl DA, Posin JP and Kaufman L: The value of relaxation times and density measurements in clinical MRI. Invest Radiol 1987 Feb;22(2):158-69. | |
|
Crooks LE, Arakawa M, Hylton NM, Avram HE, Hoenninger JC, Watts JC, Hale J and Kaufman L. Echo-planar pediatric imager. Radiology 1988 Jan;166:157-63. | |
|
Hylton NM, Chung WS, Botvinick EH, Schiller NB, Sheldon PS and Kaufman L: Oblique reformatting of multislice MR images for improved visualization of coronary arteries. J of Digit Imaging 1990 Feb;3(1):34-37. | |
|
Hylton NM, Simovsky I, Li AJ, Hale JD. Impact of section doubling on MR angiography. Radiology 1992 Dec;185(3):899-902. | |
|
Bourne MW, Margerun L, Hylton N, Campion B, Lai JJ, Derugin N, Higgins CB. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. J Magn Reson Imaging. 1996 Mar-Apr;6(2):305-10. | |
|
Hylton NM, Frankel SD. Imaging Techniques for Breast MRI. In Breast Imaging. Magn Reson Imaging Clin N Am. 1994 Nov;2(4):511-25. | |
|
Hylton NM, Kinkel K. Technical Aspects of breast magnetic resonance imaging. Top Magn Reson Imaging. 1998 Feb; 9(1):3-16. | |
|
Esserman LJ, Hylton NM, Yassa L, Frankel S and Weidner N. Utility of MRI in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol, 1999 Jan, 17(1):110-19. | |
|
Esserman LJ, Hylton NM, George T and Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J, 1999 Jan; 5(1):13-21. | |
|
Hylton NM. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am, 1999 May; 7(2):411-20. | |
|
Partridge SC, Heumann EJ, Hylton NM. Semi-automated analysis for MRI of breast tumors. Stud Health Technol Inform, 1999,62:259-60. | |
|
Hylton NM. Dedicated breast MRI systems working group report. In Technical Report of the International Working Group on Breast MRI. J Magn Reson Imaging 1999 Dec;10(6):1006-9. | |
|
Kinkel K, Helbich TH, Barclay J, Schwerin EH, Esserman LJ, Sickles EA, Hylton NM. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol. 2000 Jul;175(1):35-43. | |
|
Hylton NM. Suspension of breast-feeding following gadopentetate dimeglumine administration. Editorial. Radiology 2000 Aug; 216(2):325-26. | |
|
Hylton NM. Advances in MRI of the Breast. J of Women's Imaging 2000; 2:2:54-55. | |
|
Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol 2000 Dec;175(6):1577-84. | |
|
Esserman LJ, Wolverton D, Hylton NM. Integration of breast imaging into cancer management. Curr Oncol Rep 2000 Nov, 2(6):572-81. | |
|
Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J Magn Reson Imaging 2001 Jun; 13(6):821-29. | |
|
Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl KK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001;13(6):889-95. | |
|
Esserman LJ, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, and Hylton N. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001 Jul;8(6): 549-59. | |
|
Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging. 2001 Oct;14(4):433-8. | |
|
Esserman L, Wolverton D, Hylton N. Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocr Related Cancer 2002 Jun;9(2):141-53. | |
|
Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. The accuracy of MRI for detection of residual breast cancer following neoadjuvant chemotherapy treatment. AJR Am J Roentgenol. 2002 Nov;179:1193-1199. | |
|
Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003 May-Jun;10(4):381-8.
|
|
|
11/29/04 |
|
